Clinical trials sit at a unique intersection of science, patients, and clinical care, and for decades, the “gold standard” has prioritized the rigor of the data, often at the expense of the patients providing it. This gap between rigid protocol requirements and the realities of patients' lives is a primary driver of participant hesitancy and...
Join us for this digital event designed for pharmaceutical and biopharmaceutical companies seeking reliable CDMO partnerships to accelerate their microbial programs from development through commercial manufacturing. By attending this digital event, you will learn how these capabilities come together to support efficient development, smooth scale-up, and consistent production. The presentations will also provide insight into...
In this Capabilities Update, CDMOs will share how they support ADC programs from early development through clinical and commercial manufacturing. By attending this digital event, you will gain insight into the technical expertise, scalability, and regulatory considerations required to advance ADCs efficiently. The presentations will also highlight key considerations when evaluating CDMO partners, including experience...
Difficult to purify small molecules pose a big challenge for drug developers. Working with a CDMO that has specialized expertise in chromatography ensures that no matter the purification challenges or scale, your program can be taken care of. Learn more...
Given its inherent time and resource demands, variability in productivity, and the rising complexity of monoclonal antibody (mAb) modalities—including bispecific antibodies (bsAb) and fusion proteins—cell line development (CLD) has become a leading constraint on bioprocess development. Designed to address these constraints, the Gibo™ CHOvantage™ GS CLD kit is a transposon-based CHO-K1 CLD platform that offers...
A summer outing that actually does something. Bases & Breakthroughs is built for teams. It’s an easy, high-energy way for life science companies and supporters to invest in Philadelphia while giving employees, clients, partners, and colleagues a memorable night out at the ballpark. Your ticket includes access to our pregame hospitality experience at Citizens Bank...
Celebrate 10 years of biotech innovation at UCLA. Explore the future of AI in medicine with VCs, founders, and industry leaders. For the past decade, SoCal TBA has connected the biotech communities of Southern California and Taiwan. This year’s theme, “From Foundations to Frontiers: AI, Innovation, and the Future of Biomedicine,” brings together leaders in...
As biomanufacturers face increasing pressure to boost productivity, reduce costs, and accelerate timelines, traditional scale-up approaches can introduce variability and performance drift. Intensified upstream processing offers a more scalable, efficient path forward—helping maintain product quality, process stability, and regulatory compliance from development through GMP manufacturing. In this webinar, Thermo Fisher Scientific experts share best practices...
Study build inefficiency is rarely caused by a single failure point. Instead, delays accumulate across fragmented protocol interpretation, manual configuration, iterative amendments, and validation cycles that often surface issues late—when they are more costly to resolve. For many sponsors and CROs, this has become the accepted baseline. The more important question is whether it needs...
Biocom is pleased to announce our upcoming Venture Hub Showcase—an international pitch event taking place during the 2026 BIO International Convention. This event offers a valuable opportunity to connect with potential strategic partners and investors, while exploring the latest life science innovations from fellow industry leaders. Light snacks and refreshments will be provided.
